Minorities Plan Snubs Industry Input

Before parting with money to fund the NSF program, corporate backers demand to play a greater role in charting its development WASHINGTON--The National Science Foundation wants industry to invest more than $100 million in a new minority education program that would produce 50,000 baccalaureates and 2,000 Ph.D.'s a year in science and engineering by the year 2000. What the NSF doesn't want, say officials organizing the program, is a lot of advice from the businesses on how to set it up. That an

Written byDiana Morgan
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


Before parting with money to fund the NSF program, corporate backers demand to play a greater role in charting its development
WASHINGTON--The National Science Foundation wants industry to invest more than $100 million in a new minority education program that would produce 50,000 baccalaureates and 2,000 Ph.D.'s a year in science and engineering by the year 2000. What the NSF doesn't want, say officials organizing the program, is a lot of advice from the businesses on how to set it up. That angers some of the company representatives who attended an NSF meeting in August to learn more about the program.

The meeting, NSF's National Leadership Forum, to which 100 representatives of high-tech industries, academia, professional societies and other federal agencies had been invited, was called to showcase the agency's new Alliance for Minority Participation (AMP) program. NSF outlined its plans to spend $10 million next year in a university-based ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies